Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Lyophilisation: Freeze-Drying in Pharmaceuticals and Biopharmaceuticals

25 Feb 2013 - 26 Feb 2013 - London, UK



Bookmark and Share


SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals, with key talks from Medimmune, GSK Biologicals, National Institute for Biological Standards & Control and Roche on the best practices, novel discoveries and industry innovations that are essential to the development of a company’s lyophilisation process. This conference is not to be missed as this is the forum for you to learn, explore and discover the cutting edge areas of the industry, and the essential ways a company can improve its freeze drying methods.

Benefits of attending include:                                                                         Learn of formulation techniques that assist in the lyophilisation process, and how to apply these to your own technical issues

·         Explore the latest research and development in the industry, and how these have led to improved lyophilisation cycles, both pre, and post up-scaling

·         Discover the potential technical and logistical difficulties encountered in all levels of the lyophilisation process

·         Consider the regulations in chemical engineering and how compliance can be achieved

·         Examine previous examples of up-scaling in the industry, and how to apply these to your own freeze-drying process

·         Hear about regulations, monitoring and risk reduction, to improve the cost effectiveness of the cycle, and how these can be used to manage risks and adapt to the problems encountered

Key speakers include:

 Yves Mayeresse, Director of Manufacturing, GSK Biologicals

·         Sajal Patel, Scientist II, MedImmune

·         Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim

·         Paul Matejtschuk, Principal Scientist, National Institute For Biological Standards & Control

Sune Klint Andersen, Principal Scientist Drying Processes, Novo Nordisk A/s          

       Jean René Authelin, Global Head of Pharmaceutical Engineering, Pharmaceutical Sciences, Sanofi R&D

·         Ahmad Abdul-Fattah, Group Leader, Late Stage Pharmaceutical and Processing Development, Roche

 Register at http://www.smi-online.co.uk/goto/lyophilisation-conference.asp

Or alternatively contact Annie Blundell on tel +44 (0)20 7827 6090 or email: ablundell@smi-online.co.uk



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Monkeys Protected by Zika DNA Vaccine
Experimental Zika virus DNA vaccines successfully protected monkeys against Zika infection.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!